SYNERGENE THERAPEUTICS, INC. — Department of Health and Human Services SBIR Phase I: SBIR Phase II to develop a LYOPHILLIZED form of Optimized scL-gad-d complex
SYNERGENE THERAPEUTICS, INC. — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $498,331
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- NAICS
- —
- Place of performance
- MD
- Period
- —
Description
SBIR Phase II to develop a LYOPHILLIZED form of Optimized scL-gad-d complex